S. Mortillo

发表

Structure of the mouse egg extracellular coat, the zona pellucida.

P. Wassarman, S. Mortillo, P. M. Wassarman, 1991, International review of cytology.

Targeted disruption of the mZP3 gene results in production of eggs lacking a zona pellucida and infertility in female mice.

P. Wassarman, E. Litscher, C. Stewart, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases

J. Fargnoli, J. Barrish, J. Hunt, 2010, Molecular Cancer Therapeutics.

Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.

J. Fargnoli, J. Barrish, J. Tokarski, 2005, Journal of medicinal chemistry.

Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.

Punit Marathe, Ravindra Tejwani, Arvind Mathur, 2008, Bioorganic & medicinal chemistry letters.

Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)

J. Fargnoli, G. Derbin, J. Barrish, 2008, Journal of medicinal chemistry.

Transgenic mouse eggs with functional hamster sperm receptors in their zona pellucida.

P. Wassarman, R. A. Kinloch, S. Mortillo, 1992, Development.

Differential binding of gold-labeled zona pellucida glycoproteins mZP2 and mZP3 to mouse sperm membrane compartments.

P. Wassarman, S. Mortillo, P. M. Wassarman, 1991, Development.

The Mouse Egg Receptor For Sperm: A Multifunctional Zona Pellucida Glycoprotein

P. Wassarman, R. Roller, H. Florman, 1989 .

The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure

W. Janssen, S. Mahata, G. Pasinetti, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Compensatory redistribution of neuroligins and N‐cadherin following deletion of synaptic β1‐integrin

Yongchao Ge, D. Benson, G. W. Huntley, 2012, The Journal of comparative neurology.

Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template.

J. Fargnoli, J. Hunt, B. Fink, 2004, Journal of medicinal chemistry.

Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.

J. Fargnoli, G. Derbin, J. Barrish, 2006, Journal of medicinal chemistry.

Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.

J. Fargnoli, J. Tokarski, J. Hunt, 2005, Bioorganic & medicinal chemistry letters.

Embryonal carcinoma cells transfected with ZP3 genes differentially glycosylate similar polypeptides and secrete active mouse sperm receptor

P. Wassarman, C. Stewart, R. A. Kinloch, 1991, The Journal of cell biology.

An upstream region of the mouse ZP3 gene directs expression of firefly luciferase specifically to growing oocytes in transgenic mice.

P. Wassarman, S. Lira, R. A. Kinloch, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A·mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function*

S. Sealfon, R. Neve, Terrell Holloway, 2012, The Journal of Biological Chemistry.

Immunoultrastructural localization of Ia antigens in human endometrium.

M. Gerber, S. Mortillo, S. Tabibzadeh, 1987, Archives of pathology & laboratory medicine.

Identification of Three Residues Essential for 5-HT 2 A-mGlu 2 Receptor Heteromerization and its Psychoactive Behavioral Function

S. Sealfon, R. Neve, G. Milligan, 2012 .

Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2.

J. Fargnoli, G. Derbin, J. Barrish, 2006, Journal of medicinal chemistry.

Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.

J. Fargnoli, G. Derbin, J. Barrish, 2008, Bioorganic & medicinal chemistry letters.

Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors.

J. Fargnoli, J. Tokarski, J. Hunt, 2008, Bioorganic & medicinal chemistry letters.